The importance of validating intracranial bleeding diagnoses in The Health Improvement Network, United Kingdom: Misclassification of onset and its impact on the risk associated with low-dose aspirin therapy.

HOME
>
論文・技術情報
>
The importance of validating intracranial bleeding diagnoses in The Health Improvement Network, United Kingdom: Misclassification of onset and its impact on the risk associated with low-dose aspirin therapy.

アブストラクト
ジャーナル名	Pharmacoepidemiology and drug safety
Pubmed追加日	2018/5/29
投稿者	Cea Soriano, Lucia; Gaist, David; Soriano-Gabarro, Montse; Garcia Rodriguez, Luis A
組織名	Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain.;Department of Preventive Medicine and Public Health, Faculty of Medicine,;Complutense University of Madrid, Madrid, Spain.;Department of Neurology, Odense University Hospital and Department of Clinical;Research, Odense, Denmark.;Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.;Epidemiology, Bayer AG, Berlin, Germany.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/29806168/